Assessment of phosphatidylinositol-3 kinase (PI3K) as a prognostic marker in head and neck squamous cell carcinoma (HNSCC)
Pectasides E, Founztilas G, Sasaki C, Burtness B, Psyrri A. Assessment of phosphatidylinositol-3 kinase (PI3K) as a prognostic marker in head and neck squamous cell carcinoma (HNSCC). Journal Of Clinical Oncology 2009, 27: e17028-e17028. DOI: 10.1200/jco.2009.27.15_suppl.e17028.Peer-Reviewed Original Research